|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei EK, Giovannucci E, Wu K, Rosner B,
Fuchs CS, Willett WC and Colditz GA: Comparison of risk factors for
colon and rectal cancer. Int J Cancer. 108:433–442. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Simmonds PC: Palliative chemotherapy for
advanced colorectal cancer: Systematic review and meta-analysis.
Colorectal Cancer Collaborative Group. BMJ. 321:531–535. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miyashita K, Nishikawa S, Beppu F, Tsukui
T, Abe M and Hosokawa M: The allenic carotenoid fucoxanthin, a
novel marine nutraceutical from brown seaweeds. J Sci Food Agric.
91:1166–1174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hosokawa M, Kudo M, Maeda H, Kohno H,
Tanaka T and Miyashita K: Fucoxanthin induces apoptosis and
enhances the antiproliferative effect of the PPARgamma ligand,
troglitazone, on colon cancer cells. Biochim Biophys Acta.
1675:113–119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kotake-Nara E, Asai A and Nagao A:
Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate
cancer cells. Cancer Lett. 220:75–84. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Z, Zhang P, Hamada M, Takahashi S,
Xing G, Liu J and Sugiura N: Potential chemoprevention effect of
dietary fucoxanthin on urinary bladder cancer EJ-1 cell line. Oncol
Rep. 20:1099–1103. 2008.PubMed/NCBI
|
|
8
|
Das SK, Hashimoto T and Kanazawa K: Growth
inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is
associated with down-regulation of cyclin D. Biochim Biophys Acta.
1780:743–749. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hosokawa M, Wanezaki S, Miyauchi K,
Kurihara H, Kohno H, Kawabata J, Odashima S and Takahashi K:
Apoptosis-inducing effect of fucoxanthin on human leukemia cell
line HL-60. Food Sci Technol Res. 5:243–246. 1999. View Article : Google Scholar
|
|
10
|
Konishi I, Hosokawa M, Sashima T,
Kobayashi H and Miyashita K: Halocynthiaxanthin and fucoxanthinol
isolated from Halocynthia roretzi induce apoptosis in human
leukemia, breast and colon cancer cells. Comp Biochem Physiol C
Toxicol Pharmacol. 142:53–59. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kobayashi H, Tanisaka K, Kondo N, et al:
Development of new in vitro chemosensitivity test using
collagen gel droplet embedded culture and its clinical usefulness.
Gan To Kagaku Ryoho. 22:1933–1939. 1995.(In Japanese). PubMed/NCBI
|
|
12
|
Kobayashi H: Development of a new in
vitro chemosensitivity test using collagen gel droplet embedded
culture and image analysis for clinical usefulness. Recent Results
Cancer Res. 161:48–61. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kobayashi H: Collagen gel droplet culture
method to examine in vitro chemosensitivity. Methods Mol
Med. 110:59–67. 2005.PubMed/NCBI
|
|
14
|
Asai A, Sugawara T, Ono H and Nagao A:
Biotransformation of fucoxanthinol into amarouciaxanthin A in mice
and HepG2 cells: Formation and cytotoxicity of fucoxanthin
metabolites. Drug Metab Dispos. 32:205–211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hashimoto T, Ozaki Y, Taminato M, Das SK,
Mizuno M, Yoshimura K, Maoka T and Kanazawa K: The distribution and
accumulation of fucoxanthin and its metabolites after oral
administration in mice. Br J Nutr. 102:242–248. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Airanthi MK, Sasaki N, Iwasaki S, Baba N,
Abe M, Hosokawa M and Miyashita K: Effect of brown seaweed lipids
on fatty acid composition and lipid hydroperoxide levels of mouse
liver. J Agric Food Chem. 59:4156–4163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hashimoto T, Ozaki Y, Mizuno M, Yoshida M,
Nishitani Y, Azuma T, Komoto A, Maoka T, Tanino Y and Kanazawa K:
Pharmacokinetics of fucoxanthinol in human plasma after the oral
administration of kombu extract. Br J Nutr. 107:1566–1569. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Das SK, Hashimoto T, Shimizu K, Yoshida T,
Sakai T, Sowa Y, Komoto A and Kanazawa K: Fucoxanthin induces cell
cycle arrest at G0/G1 phase in human colon carcinoma cells through
up-regulation of p21WAF1/Cip1. Biochim Biophys Acta. 1726:328–335.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim KN, Ahn G, Heo SJ, Kang SM, Kang MC,
Yang HM, Kim D, Roh SW, Kim SK, Jeon BT, et al: Inhibition of tumor
growth in vitro and in vivo by fucoxanthin against
melanoma B16F10 cells. Environ Toxicol Pharmacol. 35:39–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Imbs TI, Ermakova SP, Fedoreyev SA,
Anastyuk SD and Zvyagintseva TN: Isolation of fucoxanthin and
highly unsaturated monogalactosyldiacylglycerol from brown alga
Fucus evanescens c agardh and in vitro investigation
of their antitumor activity. Mar Biotechnol (NY). 15:606–612. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Beppu F, Niwano Y, Tsukui T, Hosokawa M
and Miyashita K: Single and repeated oral dose toxicity study of
fucoxanthin (FX), a marine carotenoid, in mice. J Toxicol Sci.
34:501–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
